This could be relevant for the DA overdose hypothesis of iatrogenic cognitive impairments associated with dopaminergic drug treatment in PD [42], as our data suggest that such effects are driven by D1R in the NAcS and D2R in the NAcC. The gene discussed is DRD2; the disease is Parkinson disease.